Trial intelligence / Profile preview

Nebivolol Effects on Nitric Oxide in Essential Hypertension

NCT01679652Phase 2Completed

Start
Aug 2012
Primary completion
Sep 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of nebivolol in essential hypertension. Started Aug 2012; status: completed.

02

Drugs

nebivolol
03

Conditions

essential hypertension

Beyond the preview

Go deeper on NCT01679652.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01679652.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call